Your browser doesn't support javascript.
loading
Immediate versus deferred chemotherapy after radical cystectomy in patients with pT3-pT4 or N+ M0 urothelial carcinoma of the bladder (EORTC 30994): an intergroup, open-label, randomised phase 3 trial.
Sternberg, Cora N; Skoneczna, Iwona; Kerst, J Martijn; Albers, Peter; Fossa, Sophie D; Agerbaek, Mads; Dumez, Herlinde; de Santis, Maria; Théodore, Christine; Leahy, Michael G; Chester, John D; Verbaeys, Antony; Daugaard, Gedske; Wood, Lori; Witjes, J Alfred; de Wit, Ronald; Geoffrois, Lionel; Sengelov, Lisa; Thalmann, George; Charpentier, Danielle; Rolland, Frédéric; Mignot, Laurent; Sundar, Santhanam; Symonds, Paul; Graham, John; Joly, Florence; Marreaud, Sandrine; Collette, Laurence; Sylvester, Richard.
  • Sternberg CN; San Camillo and Forlanini Hospitals, Rome, Italy. Electronic address: cstern@mclink.it.
  • Skoneczna I; Maria Sklodowska-Curie Memorial Cancer Centre, Warsaw, Poland.
  • Kerst JM; The Netherlands Cancer Institute, Amsterdam, Netherlands.
  • Albers P; Klinikum Kassel, Kassel, Germany; University Clinic Bonn, Bonn, Germany.
  • Fossa SD; Oslo University Hospital, Oslo, Norway.
  • Agerbaek M; Aarhus University Hospital, Aarhus, Denmark.
  • Dumez H; KU Leuven-University of Leuven, University Hospitals Leuven, Department of General Medical Oncology, Leuven, Belgium.
  • de Santis M; Ludwig Boltzmann Institute for Applied Cancer Research (LBI-ACR VIEnna)-LB Cluster Translational Oncology (LB-CTO), Kaiser Franz Josef-Spital, Vienna, Austria.
  • Théodore C; Hôpital Foch, Suresnes, France; Institut Gustave Roussy, Villejuif, France.
  • Leahy MG; St James's University Hospital, Leeds, UK.
  • Chester JD; St James's University Hospital, Leeds, UK; Cardiff University and Velindre Cancer Center, Cardiff, UK.
  • Verbaeys A; University Hospital Ghent, Ghent, Belgium.
  • Daugaard G; Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
  • Wood L; QEII Health Sciences Centre, Dalhousie University Halifax, NS, Canada.
  • Witjes JA; Radboud University Medical Center Nijmegen, Nijmegen, Netherlands.
  • de Wit R; Erasmus University Medical Center, Rotterdam, Netherlands.
  • Geoffrois L; Institut de Cancérologie de Lorraine-Alexis Vautrin, Vandoeuvre-Les-Nancy, France.
  • Sengelov L; Herlev Hospital, University of Copenhagen, Copenhagen, Denmark.
  • Thalmann G; Inselspital, Bern, Switzerland.
  • Charpentier D; Centre Hospitalier de l'Université de Montreal-Hôpital Notre-Dame, Montreal, QC, Canada.
  • Rolland F; Institut de Cancérologie de l'Ouest-Centre Rene Gauducheau, St Herblain, Nantes, France.
  • Mignot L; Centre Médico-Chirurgical Foch, Suresnes, France.
  • Sundar S; Nottingham University Hospitals NHS Trust-City Hospital, Nottingham, UK.
  • Symonds P; Leicester Royal Infirmary, Leicester, UK.
  • Graham J; University Hospitals Bristol NHS Foundation Trust, Bristol, UK.
  • Joly F; Centre François Baclesse, Caen, France.
  • Marreaud S; EORTC Headquarters, Brussels, Belgium.
  • Collette L; EORTC Headquarters, Brussels, Belgium.
  • Sylvester R; EORTC Headquarters, Brussels, Belgium.
Lancet Oncol ; 16(1): 76-86, 2015 Jan.
Article en En | MEDLINE | ID: mdl-25498218
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Vejiga Urinaria / Carcinoma / Protocolos de Quimioterapia Combinada Antineoplásica / Cistectomía / Urotelio / Tiempo de Tratamiento Tipo de estudio: Clinical_trials / Prognostic_studies País como asunto: America do norte / Europa Idioma: En Año: 2015 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Vejiga Urinaria / Carcinoma / Protocolos de Quimioterapia Combinada Antineoplásica / Cistectomía / Urotelio / Tiempo de Tratamiento Tipo de estudio: Clinical_trials / Prognostic_studies País como asunto: America do norte / Europa Idioma: En Año: 2015 Tipo del documento: Article